Cameron Turtle insider trades

Open-market stock purchases and sales by Cameron Turtle, Chief Executive Officer at Spyre Therapeutics, Inc, from SEC Form 4 filings since Nov 30, 2018.

Recent trades

DateStockTradeValue
Oct 1, 2026SYRE Spyre Therapeutics, IncSold$53.5K
Oct 1, 2026SYRE Spyre Therapeutics, IncSold$242K
Oct 1, 2026SYRE Spyre Therapeutics, IncSold$241K
Oct 1, 2026SYRE Spyre Therapeutics, IncSold$368K
Oct 1, 2026SYRE Spyre Therapeutics, IncSold$466K
Oct 1, 2026SYRE Spyre Therapeutics, IncSold$9.4K
Sep 1, 2026SYRE Spyre Therapeutics, IncSold$216K
Sep 1, 2026SYRE Spyre Therapeutics, IncSold$732K
Sep 1, 2026SYRE Spyre Therapeutics, IncSold$326K
Sep 1, 2026SYRE Spyre Therapeutics, IncSold$35.6K
Aug 3, 2026SYRE Spyre Therapeutics, IncSold$75.2K
Aug 3, 2026SYRE Spyre Therapeutics, IncSold$681K
Aug 3, 2026SYRE Spyre Therapeutics, IncSold$541K
Aug 3, 2026SYRE Spyre Therapeutics, IncSold$135K
Aug 3, 2026SYRE Spyre Therapeutics, IncSold$1.6K
Jul 1, 2026SYRE Spyre Therapeutics, IncSold$890K
Jul 1, 2026SYRE Spyre Therapeutics, IncSold$373K
Jul 1, 2026SYRE Spyre Therapeutics, IncSold$52.5K
Jun 1, 2026SYRE Spyre Therapeutics, IncSold$247K
Jun 1, 2026SYRE Spyre Therapeutics, IncSold$575K
Jun 1, 2026SYRE Spyre Therapeutics, IncSold$235K
May 1, 2026SYRE Spyre Therapeutics, IncSold$369K
May 1, 2026SYRE Spyre Therapeutics, IncSold$255K
May 1, 2026SYRE Spyre Therapeutics, IncSold$71.8K
May 1, 2026SYRE Spyre Therapeutics, IncSold$227K

Companies traded

  • SYRE Spyre Therapeutics, Inc: 40 sales, last Oct 1, 2026
  • DMRA Damora Therapeutics, Inc: other filings, last Mar 23, 2026
  • ORKA Oruka Therapeutics, Inc: other filings, last Jun 2, 2025
  • AGLE Spyre Therapeutics, Inc: other filings, last Nov 24, 2023
  • EIDX Eidos Therapeutics, Inc: 30 sales, last Jan 26, 2021
  • BBIO BridgeBio Pharma, Inc: 17 sales, last Dec 28, 2020

Get free alerts when Cameron Turtle files a new trade →